TY - JOUR A1 - Sötebier, Carina A1 - Weidner, Steffen A1 - Jakubowski, Norbert A1 - Panne, Ulrich A1 - Bettmer, J. T1 - Separation and quantification of silver nanoparticles and silver ions using reversed phase high performance liquid chromatography coupled to inductively coupled plasma mass spectrometry in combination with isotope dilution analysis N2 - A reversed phase high performance liquid chromatography coupled to an inductively coupled plasma mass spectrometer (HPLC-ICP-MS) approach in combination with isotope dilution analysis (IDA) for the separation and parallel quantification of nanostructured and ionic silver (Ag) is presented. The main focus of this work was the determination of the ionic Ag concentration. For a sufficient stabilization of the ions without dissolving the nanoparticles (NPs), the eluent had to be initially optimized. The determined Ag ion concentration was in a good agreement with results obtained using ultrafiltration. Further, the mechanism of the NP separation in the HPLC column was investigated. Typical size exclusion effects were found by comparing results from columns with different pore sizes. Since the recovery rates decreased with increasing Ag NP size and large Ag NPs did not elute from the column, additional interactions of the particles with the stationary phase were assumed. Our results reveal that the presented method is not only applicable to Ag NPs, but also to gold and polystyrene NPs. Finally, IDA-HPLC-ICP-MS experiments in single particle mode were performed to determine the particle cut-off size. The comparison with conventional spICP-MS experiments resulted in a similar diameter and particle size distribution. KW - ICP-MS KW - Silver nanoparticles KW - HPLC KW - Isotope dilution analysis KW - Field flow fractionation KW - Toxicology PY - 2016 U6 - https://doi.org/10.1016/j.chroma.2016.09.028 SN - 0021-9673 VL - 1468 SP - 102 EP - 108 PB - Elsevier B.V. AN - OPUS4-38642 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Sötebier, Carina A. A1 - Weidner, Steffen A1 - Jakubowski, Norbert A1 - Panne, Ulrich A1 - Bettmer, J. T1 - Separation and quantification of silver nanoparticles and silver ions using reversed phase high performance liquid chromatography coupled to inductively coupled plasma mass spectrometry in combination with isotope dilution analysis N2 - A reversed phase high performance liquid chromatography coupled to an inductively coupled Plasma mass spectrometer (HPLC–ICP-MS) approach in combination with isotope dilution analysis (IDA) for the separation and parallel quantification of nanostructured and ionic silver (Ag) is presented. The main Focus of this work was the determination of the ionic Ag concentration. For a sufficient stabilization of the Ions without dissolving the nanoparticles (NPs), the eluent had to be initially optimized. The determined Ag ion concentration was in a good agreement with results obtained using ultrafiltration. Further, the mechanism of the NP separation in the HPLC column was investigated. Typical size exclusion effects were found by comparing results from columns with different pore sizes. Since the recovery rates decreased with increasing Ag NP size and large Ag NPs did not elute from the column, additional interactions of the particles with the stationary phase were assumed. Our results reveal that the presented method is not only applicable to Ag NPs, but also to gold and polystyrene NPs. Finally, IDA-HPLC-ICP-MS experiments in single particle mode were performed to determine the particle cut-off size. The comparison with conventional spICP-MS experiments resulted in a similar diameter and particle size distribution. KW - ICP-MS KW - Silver nanoparticles KW - Speciation KW - High performance liquid chromatography KW - Isotope dilution analysis PY - 2016 U6 - https://doi.org/10.1016/j.chroma.2016.09.028 SN - 0021-9673 VL - 1468 SP - 102 EP - 108 AN - OPUS4-37652 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Böhmert, L. A1 - Girod, Matthias A1 - Hansen, Ulf A1 - Maul, Ronald A1 - Knappe, Patrick A1 - Niemann, B. A1 - Weidner, Steffen A1 - Thünemann, Andreas A1 - Lampen, A. T1 - Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells N2 - Orally ingested nanoparticles may overcome the gastrointestinal barrier, reach the circulatory system, be distributed in the organism and cause adverse health effects. However, ingested nanoparticles have to pass through different physicochemical environments, which may alter their properties before they reach the intestinal cells. In this study, silver nanoparticles are characterised physicochemically during the course of artificial digestion to simulate the biochemical processes occurring during digestion. Their cytotoxicity on intestinal cells was investigated using the Caco-2 cell model. Using field-flow fractionation combined with dynamic light scattering and small-angle X-ray scattering, the authors found that particles only partially aggregate as a result of the digestive process. Cell viabilities were determined by means of CellTiter-Blue® assay, 4',6-diamidino-2-phenylindole-staining and real-time impedance. These measurements reveal small differences between digested and undigested particles (1–100 µg/ml or 1–69 particles/cell). The findings suggest that silver nanoparticles may indeed overcome the gastrointestinal juices in their particulate form without forming large quantities of aggregates. Consequently, the authors presume that the particles can reach the intestinal epithelial cells after ingestion with only a slight reduction in their cytotoxic potential. The study indicates that it is important to determine the impact of body fluids on the nanoparticles of interest to provide a reliable interpretation of their nano-specific cytotoxicity testing in vivo and in vitro. KW - Silver nanoparticles KW - In vitro digestion KW - Field-flow fractionation KW - Small-angle X-ray scattering KW - Dynamic light scattering KW - Caco-2 cells PY - 2014 U6 - https://doi.org/10.3109/17435390.2013.815284 SN - 1743-5390 SN - 1743-5404 VL - 8 IS - 6 SP - 631 EP - 642 PB - Informa Healthcare CY - London AN - OPUS4-29926 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -